UK Antibodies Supply
key details
| Value | £1 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Deadline | 23 Dec 2020 |
| Contract start | 1 Apr 2021 |
| Contract end | 30 Jun 2022 |
| SME suitable | Yes |
| OCID | ocds-b5fd17-9b2a2b90-72ab-4469-9cc9-dfcdd77616c5 |
description
COVID-19 requires over 500,000 'at risk' people in the UK to be protected via antibody prophylaxis as they are unlikely to benefit from a vaccine. Demand for antibody prophylaxis is estimated at up to 1.5million 1g doses of an antibody cocktail (containing two antibodies @0.5g each) per annum. Current UK manufacturing supply chains do not have capacity to produce these levels. To secure this and ensure the UK is best placed to respond to future requirements, by assuring supply chain resilience and access, the Department is seeking to engage the market to explore how UK antibody manufacturing capability can be developed. The target is for capability to reach 1.5m 1g doses of antibody cocktail pa under Good Manufacturing Process by the end of Q2 2022.
documents
- https://www.contractsfinder.service.gov.uk/Notice/cb745683-b597-4216-9773-43eebf22c784 , tenderNotice
- https://www.delta-esourcing.com/delta/respondToList.html?noticeId=535012293 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Oct 2020 | Tender (tender) | · | cb745683-b597-4216-9773-43eebf22c784-388041 |
more from The Department for Business, Energy and Industrial Strategy (BEIS)
- PS21172 - Energy and Climate Change Behavioural Science Framework · £1,500,000 · 5 Apr 2024
- UK SBS - PS22125 - Construction Products Systems Mapping · £150,000 · 28 Apr 2023
- UKSBS - PS22132 Operating Agent for an IEA Annex on Retrofitting Heat Pumps in Large Non-Domestic Buildings · £145,000 · 16 May 2022
- Development of a Publicly Available Specification (PAS) for Energy Savings Opportunity Scheme (ESOS) net zero audits · £247,000 · 12 Apr 2022
- Domestic Private Rented Sector Evaluation - Landlord Panel Survey · £24,630 · 12 Apr 2022
- 1:1 Market Engagement Sessions - Nuclear Monitors Supply and Maintenance [amended] · 11 Feb 2022
- Heat Pump Ready Programme - Stream 3: Trial Support and Learning · £5,000,000 · 17 Jan 2022
- Flexibility Innovation Programme: Programme Management Contractor (PMC) · £4,150,000 · 13 Jan 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.